triiodothyronine has been researched along with Bulimia in 14 studies
Triiodothyronine: A T3 thyroid hormone normally synthesized and secreted by the thyroid gland in much smaller quantities than thyroxine (T4). Most T3 is derived from peripheral monodeiodination of T4 at the 5' position of the outer ring of the iodothyronine nucleus. The hormone finally delivered and used by the tissues is mainly T3.
3,3',5-triiodo-L-thyronine : An iodothyronine compound having iodo substituents at the 3-, 3'- and 5-positions. Although some is produced in the thyroid, most of the 3,3',5-triiodo-L-thyronine in the body is generated by mono-deiodination of L-thyroxine in the peripheral tissues. Its metabolic activity is about 3 to 5 times that of L-thyroxine. The sodium salt is used in the treatment of hypothyroidism.
Bulimia: Eating an excess amount of food in a short period of time, as seen in the disorder of BULIMIA NERVOSA. It is caused by an abnormal craving for food, or insatiable hunger also known as ox hunger.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In view of the important role played by the cholinergic system in the neural regulation of growth hormone (GH) secretion, the ability of pirenzepine, a selective antagonist of muscarinic cholinergic receptors, to blunt the GH response to GH-releasing hormone (GHRH) was studied in adolescent females with anorexia nervosa in the acute (AN-AP) five AN-AP patients, administration of GHRH 1-40 (1 microgram/kg IV) evoked a significantly higher GH response than in controls at established intervals, whereas in eight AN-RP and seven AED patients it was higher than in controls at only one (150-min) and two (150-min, 180-min) time intervals, respectively." | 7.68 | Blockade of cholinergic muscarinic receptors by pirenzepine and GHRH-induced GH secretion in the acute and recovery phase of anorexia nervosa and atypical eating disorders. ( Andreoni, A; Belliti, D; Cristofani, R; Ferdeghini, M; Müller, EE; Rolla, M, 1991) |
| "In view of the important role played by the cholinergic system in the neural regulation of growth hormone (GH) secretion, the ability of pirenzepine, a selective antagonist of muscarinic cholinergic receptors, to blunt the GH response to GH-releasing hormone (GHRH) was studied in adolescent females with anorexia nervosa in the acute (AN-AP) five AN-AP patients, administration of GHRH 1-40 (1 microgram/kg IV) evoked a significantly higher GH response than in controls at established intervals, whereas in eight AN-RP and seven AED patients it was higher than in controls at only one (150-min) and two (150-min, 180-min) time intervals, respectively." | 3.68 | Blockade of cholinergic muscarinic receptors by pirenzepine and GHRH-induced GH secretion in the acute and recovery phase of anorexia nervosa and atypical eating disorders. ( Andreoni, A; Belliti, D; Cristofani, R; Ferdeghini, M; Müller, EE; Rolla, M, 1991) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (28.57) | 18.7374 |
| 1990's | 7 (50.00) | 18.2507 |
| 2000's | 3 (21.43) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Monteleone, P | 2 |
| Santonastaso, P | 1 |
| Pannuto, M | 2 |
| Favaro, A | 1 |
| Caregaro, L | 1 |
| Castaldo, E | 1 |
| Zanetti, T | 1 |
| Maj, M | 2 |
| Fabrazzo, M | 1 |
| Martiadis, V | 1 |
| Serritella, C | 1 |
| Troisi, A | 1 |
| Di Lorenzo, G | 1 |
| Lega, I | 1 |
| Tesauro, M | 1 |
| Bertoli, A | 1 |
| Leo, R | 1 |
| Iantorno, M | 1 |
| Pecchioli, C | 1 |
| Rizza, S | 1 |
| Turriziani, M | 1 |
| Lauro, R | 1 |
| Siracusano, A | 1 |
| Spalter, AR | 1 |
| Gwirtsman, HE | 1 |
| Demitrack, MA | 1 |
| Gold, PW | 2 |
| Laessle, RG | 3 |
| Platte, P | 1 |
| Schweiger, U | 3 |
| Pirke, KM | 6 |
| Fichter, MM | 1 |
| Altemus, M | 1 |
| Hetherington, MM | 1 |
| Flood, M | 1 |
| Licinio, J | 1 |
| Nelson, ML | 1 |
| Bernat, AS | 1 |
| Lautenbacher, S | 1 |
| Pauls, AM | 1 |
| Strian, F | 1 |
| Krieg, JC | 3 |
| Rolla, M | 1 |
| Andreoni, A | 1 |
| Belliti, D | 1 |
| Cristofani, R | 1 |
| Ferdeghini, M | 1 |
| Müller, EE | 1 |
| Obarzanek, E | 1 |
| Lesem, MD | 1 |
| Goldstein, DS | 1 |
| Jimerson, DC | 1 |
| Lauer, C | 2 |
| Kiyohara, K | 1 |
| Tamai, H | 1 |
| Kobayashi, N | 1 |
| Nakagawa, T | 1 |
14 other studies available for triiodothyronine and Bulimia
| Article | Year |
|---|---|
Enhanced serum cholesterol and triglyceride levels in bulimia nervosa: relationships to psychiatric comorbidity, psychopathology and hormonal variables.
Topics: Adult; Anorexia Nervosa; Blood Glucose; Borderline Personality Disorder; Bulimia; Cholesterol; Comor | 2005 |
Circulating brain-derived neurotrophic factor is decreased in women with anorexia and bulimia nervosa but not in women with binge-eating disorder: relationships to co-morbid depression, psychopathology and hormonal variables.
Topics: Adult; Anorexia Nervosa; Body Mass Index; Brain-Derived Neurotrophic Factor; Bulimia; Comorbidity; D | 2005 |
Plasma ghrelin in anorexia, bulimia, and binge-eating disorder: relations with eating patterns and circulating concentrations of cortisol and thyroid hormones.
Topics: Adult; Anorexia; Body Mass Index; Bulimia; Female; Ghrelin; Humans; Hydrocortisone; Nutritional Stat | 2005 |
Thyroid function in bulimia nervosa.
Topics: Adult; Body Weight; Bulimia; Energy Intake; Energy Metabolism; Euthyroid Sick Syndromes; Female; Fol | 1993 |
Biological and psychological correlates of intermittent dieting behavior in young women. A model for bulimia nervosa.
Topics: 3-Hydroxybutyric Acid; Adolescent; Adult; Affect; Body Weight; Bulimia; Diet, Reducing; Energy Intak | 1996 |
Gonadotropin secretion in bulimia nervosa.
Topics: Adult; Bulimia; Estradiol; Female; Follicle Stimulating Hormone; Humans; Hydrocortisone; Luteinizing | 1992 |
Decrease in resting metabolic rate during abstinence from bulimic behavior.
Topics: Adult; Basal Metabolism; Bulimia; Eating; Female; Humans; Thyroxine; Triiodothyronine; Vomiting; Wei | 1991 |
Pain sensitivity in anorexia nervosa and bulimia nervosa.
Topics: Adult; Anorexia Nervosa; Body Temperature Regulation; Body Weight; Bulimia; Diet, Reducing; Female; | 1991 |
Blockade of cholinergic muscarinic receptors by pirenzepine and GHRH-induced GH secretion in the acute and recovery phase of anorexia nervosa and atypical eating disorders.
Topics: Adolescent; Anorexia Nervosa; Body Weight; Brain; Bulimia; Estradiol; Female; Follicle Stimulating H | 1991 |
Reduced resting metabolic rate in patients with bulimia nervosa.
Topics: Adult; Basal Metabolism; Body Composition; Body Weight; Bulimia; Calorimetry; Eating; Exercise; Fema | 1991 |
Structural brain abnormalities in patients with bulimia nervosa.
Topics: 3-Hydroxybutyric Acid; Adolescent; Adult; Anorexia Nervosa; Atrophy; Brain; Bulimia; Cerebral Cortex | 1989 |
Hypothalamic-pituitary-thyroidal axis alterations in bulimic patients.
Topics: Adult; Body Weight; Bulimia; Female; Humans; Hypothalamo-Hypophyseal System; Thyroid Gland; Thyrotro | 1988 |
Depression as a correlate of starvation in patients with eating disorders.
Topics: 3-Hydroxybutyric Acid; Adult; Anorexia Nervosa; Body Image; Body Weight; Bulimia; Depressive Disorde | 1988 |
Hormonal and metabolic mechanisms in the development of cerebral pseudoatrophy in eating disorders.
Topics: Anorexia Nervosa; Atrophy; Bulimia; Cerebral Cortex; Cerebral Ventricles; Energy Metabolism; Hormone | 1987 |